The 200 most influential publications in migraine research: a bibliometric mapping of the intellectual landscape

偏头痛研究领域最具影响力的200篇出版物:知识格局的文献计量分析

阅读:2

Abstract

BACKGROUND: Migraine is a prevalent and highly disabling neurological disorder. A systematic evaluation of its foundational literature is essential for advancing management strategies. This study employed bibliometric methods to trace the historical trajectory of migraine research and identify principal developmental trends. METHODS: The Web of Science and PubMed database was searched to identify the 200 most highly cited publications, filtered by date, language, and document type. Comprehensive analyses and visualizations were conducted using bibliometrix (R), VOSviewer, Scimago Graphica, CiteSpace, and Microsoft Excel. RESULTS: The selected publications appeared in 45 journals across 45 countries, authored by 4,409 researchers from 1,592 institutions. Together, these works incorporated 860 keywords and cited 7,995 references. Neurology, Cephalalgia, and Headache were the leading journals, while Lipton RB and Goadsby PJ were the most influential authors. The United States led in publication volume, with Albert Einstein College of Medicine among the top institutions. Ten landmark papers were highlighted, and their contributions, along with those of the broader corpus, were systematically reviewed. Key research hotspots were also delineated. CONCLUSION: Current high-impact research emphasizes treatment, therapeutic targets, genetics, the trigeminovascular system, pain modulation, neuroimmunology, aura, and comorbidities. Recent studies confirm sustained interest in these areas, with increasing focus on the brain-gut axis. Future directions include deeper investigation of migraine pathophysiology, especially the calcitonin gene-related peptide system and episodic migraine subtypes. Rigorous methodologies and emerging technologies will enhance evidence-based evaluations of long-term safety and efficacy, while multidimensional assessments of pharmacological and non-pharmacological therapies are expected to expand.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。